IFP Advisors
MAZE icon

IFP Advisors’s Maze Therapeutics MAZE Stock Holding History

IFP Advisors’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.09K Sell
261
-67
-20% -$1.86K ﹤0.01% 3615
2026
Q2 		$9.8K Sell
328
-8,660
-96% -$227K ﹤0.01% 3405
2026
Q1 		$268K Buy
8,988
+5,474
+156% +$242K 0.01% 1247
2025
Q4 		$146K Buy
+3,514
New +$121K ﹤0.01% 1552
2025
Q3 		– Sell
-3
Closed -$37 – 4970
2025
Q2 		$37 Buy
+3
New +$31 ﹤0.01% 4818

Other funds holding MAZE

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Financial Consulate
Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

IFP Advisors's MAZE Position: Q3 2026 in Review

IFP Advisors reduced its Maze Therapeutics (MAZE) stake by 20% in Q3 2026, selling an estimated $1.86K and leaving 261 shares worth $7.09K. The position accounts for ﹤0.01% of the portfolio, ranked #3615.

IFP Advisors first reported a position in MAZE in Q2 2025 and has held it in 5 quarters since. The position peaked at $268K in Q1 2026. 11 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • IFP Advisors held 261 shares of Maze Therapeutics worth $7.09K as of Q3 2026.
  • IFP Advisors sold 67 Maze Therapeutics shares in Q3 2026, an estimated $1.86K.
  • Maze Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3615 holding.
  • IFP Advisors first reported a position in Maze Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • IFP Advisors's Maze Therapeutics position peaked at $268K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.